Bayer open for drug licensing deals, cutting debt remains priority
September 5, 2018Goldman drops bitcoin trading plans for now: Business Insider
September 5, 2018Bayer cuts forecasts on Monsanto delay as lawsuits pile up
at
Bayer cut its earnings forecast on Wednesday due to delays to its $63 billion takeover of Monsanto, and said sales of its consumer care products fell, hitting its shares, already reeling from a legal battle over the weed killer Roundup.
Powered by WPeMatico
